04:56 PM EDT, 07/02/2025 (MT Newswires) -- Lixte Biotechnology ( LIXT ) said late Wednesday it has closed its private placement to investors of $5 million securities, including shares, series B convertible preferred stock and warrants.

Investors were also able to buy pre-funded warrants in the offering in lieu of stock, it said.

Net proceeds from the offering will be used for general corporate purposes and working capital, the company said.